ImClone Investigational Site

Louisville, Kentucky 40202

0 studies enrolling now · 6 studies all time

What they study most

Colorectal Cancer, Colorectal Neoplasms, Metastases, Neoplasm, Non-small Cell Lung Cancer

Studies at this site

• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer — Completed
• Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed
• Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed